Expression of Inflammation-Associated MicroRNAs in Epilepsy
Main Author: | |
---|---|
Publication Date: | 2015 |
Other Authors: | , , , , , , , , |
Language: | eng |
Source: | Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
Download full: | http://hdl.handle.net/10400.18/3578 |
Summary: | Background: Neuroinflammation appears as an important epileptogenic mechanism. MicroRNAs (miRNA) are small non-coding RNA molecules that function as post-transcriptional regulators of gene expression, controlling different biological process including immune system homeostasis and function. Evidences, both in patients and animal studies, have demonstrated an abnormal brain expression of miR-146a and miR-155 in Mesial Temporal Lobe Epilepsy (MTLE), the most refractory epilepsy type. Knowing that miR expression is very stable in biological fluids such as plasma or serum our aim was to characterize miR-146a and miR-155 expression in serum of MTLE and GGE patients. Methods: Expression levels of miR146a and RNU48 (reference gene) were quantified by Real-Time PCR in serum of 16 MTLE patients all with Hippocampal Sclerosis (6F, 8M, mean age= 44.1±11.7 years, age of onset= 13.5±10.6 years, 7 with Febrile Seizures antecedents). A group of 24 healthy individuals was used as control. Relative expression values were calculated using the 2-ΔΔCt method. Results: MTLE patients had a higher expression of miR-146a (6 fold) and miR-155 (2 fold) when compared to controls. Conclusion: Our results, although preliminary, show that miR-146a and miR-155 may be suitable biomarkers for epileptogenesis. It is thought that these miRNAs have role in fine-tuning the response to pro-inflammatory cytokines during epileptogenesis. Nevertheless its importance in epilepsy development it is yet not fully understood. The comprehension of this role may be relevant for the development of new therapeutic strategies. |
id |
RCAP_c54b76e85af01bc5b8155e3ee0fe1798 |
---|---|
oai_identifier_str |
oai:repositorio.insa.pt:10400.18/3578 |
network_acronym_str |
RCAP |
network_name_str |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
repository_id_str |
https://opendoar.ac.uk/repository/7160 |
spelling |
Expression of Inflammation-Associated MicroRNAs in EpilepsyImmunobiologyMesial Temporal Lobe Epilepsy with Hippocampal SclerosismiRNAsEpigeneticsInflammationDeterminantes da Saúde e da DoençaDoenças GenéticasBackground: Neuroinflammation appears as an important epileptogenic mechanism. MicroRNAs (miRNA) are small non-coding RNA molecules that function as post-transcriptional regulators of gene expression, controlling different biological process including immune system homeostasis and function. Evidences, both in patients and animal studies, have demonstrated an abnormal brain expression of miR-146a and miR-155 in Mesial Temporal Lobe Epilepsy (MTLE), the most refractory epilepsy type. Knowing that miR expression is very stable in biological fluids such as plasma or serum our aim was to characterize miR-146a and miR-155 expression in serum of MTLE and GGE patients. Methods: Expression levels of miR146a and RNU48 (reference gene) were quantified by Real-Time PCR in serum of 16 MTLE patients all with Hippocampal Sclerosis (6F, 8M, mean age= 44.1±11.7 years, age of onset= 13.5±10.6 years, 7 with Febrile Seizures antecedents). A group of 24 healthy individuals was used as control. Relative expression values were calculated using the 2-ΔΔCt method. Results: MTLE patients had a higher expression of miR-146a (6 fold) and miR-155 (2 fold) when compared to controls. Conclusion: Our results, although preliminary, show that miR-146a and miR-155 may be suitable biomarkers for epileptogenesis. It is thought that these miRNAs have role in fine-tuning the response to pro-inflammatory cytokines during epileptogenesis. Nevertheless its importance in epilepsy development it is yet not fully understood. The comprehension of this role may be relevant for the development of new therapeutic strategies.Repositório Científico do Instituto Nacional de SaúdeLeal, BárbaraCarvalho, CláudiaChaves, JoãoBettencourt, AndreiaFreitas, JoelLopes, JoãoRamalheira, JoãoSilva, António M.Costa, Paulo P.Silva, Berta M.2016-03-02T15:46:23Z2015-10-282015-10-28T00:00:00Zconference objectinfo:eu-repo/semantics/publishedVersionapplication/pdfhttp://hdl.handle.net/10400.18/3578enginfo:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2025-02-26T14:24:18Zoai:repositorio.insa.pt:10400.18/3578Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T21:39:10.101471Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse |
dc.title.none.fl_str_mv |
Expression of Inflammation-Associated MicroRNAs in Epilepsy |
title |
Expression of Inflammation-Associated MicroRNAs in Epilepsy |
spellingShingle |
Expression of Inflammation-Associated MicroRNAs in Epilepsy Leal, Bárbara Immunobiology Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis miRNAs Epigenetics Inflammation Determinantes da Saúde e da Doença Doenças Genéticas |
title_short |
Expression of Inflammation-Associated MicroRNAs in Epilepsy |
title_full |
Expression of Inflammation-Associated MicroRNAs in Epilepsy |
title_fullStr |
Expression of Inflammation-Associated MicroRNAs in Epilepsy |
title_full_unstemmed |
Expression of Inflammation-Associated MicroRNAs in Epilepsy |
title_sort |
Expression of Inflammation-Associated MicroRNAs in Epilepsy |
author |
Leal, Bárbara |
author_facet |
Leal, Bárbara Carvalho, Cláudia Chaves, João Bettencourt, Andreia Freitas, Joel Lopes, João Ramalheira, João Silva, António M. Costa, Paulo P. Silva, Berta M. |
author_role |
author |
author2 |
Carvalho, Cláudia Chaves, João Bettencourt, Andreia Freitas, Joel Lopes, João Ramalheira, João Silva, António M. Costa, Paulo P. Silva, Berta M. |
author2_role |
author author author author author author author author author |
dc.contributor.none.fl_str_mv |
Repositório Científico do Instituto Nacional de Saúde |
dc.contributor.author.fl_str_mv |
Leal, Bárbara Carvalho, Cláudia Chaves, João Bettencourt, Andreia Freitas, Joel Lopes, João Ramalheira, João Silva, António M. Costa, Paulo P. Silva, Berta M. |
dc.subject.por.fl_str_mv |
Immunobiology Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis miRNAs Epigenetics Inflammation Determinantes da Saúde e da Doença Doenças Genéticas |
topic |
Immunobiology Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis miRNAs Epigenetics Inflammation Determinantes da Saúde e da Doença Doenças Genéticas |
description |
Background: Neuroinflammation appears as an important epileptogenic mechanism. MicroRNAs (miRNA) are small non-coding RNA molecules that function as post-transcriptional regulators of gene expression, controlling different biological process including immune system homeostasis and function. Evidences, both in patients and animal studies, have demonstrated an abnormal brain expression of miR-146a and miR-155 in Mesial Temporal Lobe Epilepsy (MTLE), the most refractory epilepsy type. Knowing that miR expression is very stable in biological fluids such as plasma or serum our aim was to characterize miR-146a and miR-155 expression in serum of MTLE and GGE patients. Methods: Expression levels of miR146a and RNU48 (reference gene) were quantified by Real-Time PCR in serum of 16 MTLE patients all with Hippocampal Sclerosis (6F, 8M, mean age= 44.1±11.7 years, age of onset= 13.5±10.6 years, 7 with Febrile Seizures antecedents). A group of 24 healthy individuals was used as control. Relative expression values were calculated using the 2-ΔΔCt method. Results: MTLE patients had a higher expression of miR-146a (6 fold) and miR-155 (2 fold) when compared to controls. Conclusion: Our results, although preliminary, show that miR-146a and miR-155 may be suitable biomarkers for epileptogenesis. It is thought that these miRNAs have role in fine-tuning the response to pro-inflammatory cytokines during epileptogenesis. Nevertheless its importance in epilepsy development it is yet not fully understood. The comprehension of this role may be relevant for the development of new therapeutic strategies. |
publishDate |
2015 |
dc.date.none.fl_str_mv |
2015-10-28 2015-10-28T00:00:00Z 2016-03-02T15:46:23Z |
dc.type.driver.fl_str_mv |
conference object |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10400.18/3578 |
url |
http://hdl.handle.net/10400.18/3578 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia instacron:RCAAP |
instname_str |
FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
collection |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
repository.name.fl_str_mv |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia |
repository.mail.fl_str_mv |
info@rcaap.pt |
_version_ |
1833599365090902016 |